Winston Wong, PharmD

Editor's Page

Implications of the Changing Landscape in Acute Myeloid Leukemia for Clinical Pathways

05/21/2018

Acute myelogenous leukemia (AML) is a rapid progressing malignancy of the myeloid progenitor cells, characterized by an uncontrolled proliferation of primitive blast cells replacing normal bone marrow cells. It is...

Acute...

05/21/2018

Journal of Clinical Pathways

Editor's Page

The Roles of Comprehensive Genomic Profiling, Next-Generation Sequencing, and AI in the Oncology Treatment Landscape

09/19/2023

Winston Wong , PharmD;

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, highlighting the latest scientific developments in genetic testing for oncology biomarkers into clinical care.

Editor-in-Chief Winston Wong,...

09/19/2023

Journal of Clinical Pathways

Counterpoint

ASCO Policy Statement on Clinical Pathways in Oncology Represents Great Progress for Clinical Pathways

03/08/2016

Winston Wong , PharmD;

The ASCO Policy Statement on Oncology Clinical Pathways shows how far clinical pathways have come in gaining acceptance among providers and supports their potential for improving the value of cancer care. The...

The...

03/08/2016

Journal of Clinical Pathways

Editor's Page

Real-World Data Analysis and Considerations for Use

03/16/2020

Winston Wong , PharmD;

Google the question “what is real-world evidence.” One of the first citations will be a link to the Food and Drug Administration (FDA) page defining both real-world evidence (RWE) and real-world data (RWD). The FDA...

Google...

03/16/2020

Journal of Clinical Pathways

Editor Insights

09/12/2018

Winston Wong , PharmD;

Winston Wong, PharmD, breaks down the ASCO position statement on the utilization of biosimilars in oncology and ways in which the anticipated cost-savings may be achieved.

Winston Wong, PharmD, breaks...

09/12/2018

Journal of Clinical Pathways

Editor's Page

Balancing Costs and Patient Safety When Navigating New Regulations

08/22/2018

Winston Wong , PharmD;

As new and exciting advancements in cancer drugs and care are made, updated guidance and regulations must follow. Oncologists and other stakeholders must keep up with the latest rules and regulations in order to...

As new...

08/22/2018

Journal of Clinical Pathways

Editor's Page

Pathways for Improving Quality of Life

06/20/2016

Winston Wong , PharmD;

As early detection of cancers and improved treatments continue to improve outcomes for patients with cancer, care providers have been able to increase their focus on the quality of life for patients with cancer who...

As...

06/20/2016

Journal of Clinical Pathways

Editor's Page

A Call to Action

02/15/2022

Winston Wong , PharmD;

Winston Wong, PharmD, Editor-in-Chief discusses the scope of Journal of Clinical Pathway's growth since its establishment in 2015, calling on a need to also expand the expertise of the Journal's peer reviewers.

Winston Wong, PharmD,...

02/15/2022

Journal of Clinical Pathways

Editor's Page

Biomarker Testing and Prospective Tracking Tools

10/18/2019

Winston Wong , PharmD;

Even though researchers are making progress every day, the precision medicine approach to cancer treatment is not yet part of routine care. Another strategy that can contribute to more personalized medicine is the...

Even...

10/18/2019

Journal of Clinical Pathways

Preventive Care and the Patient Voice on the Road to Value-Based Care

04/22/2021

Winston Wong , PharmD;

Chronic diseases are a tremendous burden to both patients and the health care system. Preventive strategies are available for many chronic diseases; these strategies include reducing risk factors, detecting and...

...

04/22/2021

Journal of Clinical Pathways